Adrenal carcinoma presenting as Conn's syndrome

Australian and New Zealand Journal of Medicine

Volumn 27, Issue 2, 1997, Pages 201-202

  Taylor, W ^a   Carroll, D ^a   Bethwaite, P ^a  

^a Hutt Valley Health   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CREATININE; HYDROCORTISONE; HYDROXYPROGESTERONE; POTASSIUM; PRASTERONE SULFATE; RENIN; SODIUM; TESTOSTERONE;

ADRENAL CORTEX CARCINOMA; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; SODIUM BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

EID: 0030957769     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1997.tb00953.x     Document Type: Article

References (6)

1. Brodie B, Novick AC, Pontes JE et al. The Cleveland Clinic experience with adrenal cortical carcinoma. J Urol 1989; 141: 257-60.
2. Case records of the Massachusetts General Hospital - weekly clinico-pathological exercises. Case 24-1992. A 52 year old man with hypertension, hypokalaemia and an adrenal mass. N Engl J Med 1992; 326: 1617-23.
3. Aupetit-Faisant B, Battaglia C, Zenatti M, Emeric-Blanchouin N, Legrand JC. Hyperaldosteronism accompanied by a normal or elevated mineralocorticosteroid pathway steroid: a marker of adrenal carcinoma. J Clin Endo Metab 1993; 76: 38-43.
4. Barksdale SK, Marincola FM, Jaffe G. Carcinosarcoma of the adrenal cortex presenting with mineralocorticoid excess. Am J Surg Path 1993; 17: 941-5.
5. Isles CG, Macdougall IC, Lever AF, Fraser R. Hypermineralocorticolism due to adrenal carcinoma: plasma corticosteroids and their response to ACTH and angiotensin II. Clin Endocrinol 1987; 26: 239-51.
6. Puvaneswary M, Thong K. Primary hyperaldosteronism due to adrenal cortical carcinoma. Australas Radiol 1993; 37: 88-9.